4
Changes in Ownership
LEXICON PHARMACEUTICALS, INC. Filed Acc 0001127602-24-007612
Chief Executive Officer gave up 61,371 shares (to pay taxes)
- Chief Executive Officer acquired 245,080 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
COATS LONNEL · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-28 | Exercise or conversion : show line 1 in the form | +33,333 | 947,692 | D | ||
| 2024-02-28 | Exercise or conversion : show line 2 in the form | +91,364 | 1,039,056 | D | ||
| 2024-02-28 | Exercise or conversion : show line 3 in the form | +120,383 | 1,159,439 | D | ||
| 2024-02-28 | Shares withheld for taxes : show line 4 in the form | −61,371 | $2.62 | $160,792 | 1,098,068 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-28 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −33,333 | 0 | D |
| 2024-02-28 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −91,364 | 91,363 | D |
| 2024-02-28 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −120,383 | 240,767 | D |
Loading xslF345X05/form4.xml…